Key terms
About EVOK
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest EVOK news
Mar 21
4:33pm ET
Evoke Pharma Welcomes Matthew D’Onofrio as New CEO
Mar 21
4:22pm ET
Evoke Pharma CEO David Gonyer to depart, Matthew D’Onofrio to succeed
Feb 24
10:05am ET
Evoke Pharma Faces Nasdaq Delisting Over Stock Price
Feb 10
4:57am ET
Evoke Pharma Announces Pricing of Recent Offering
Feb 10
4:57am ET
Evoke Pharma Strikes Deal to Offer Stocks and Warrants
Feb 09
7:40am ET
Evoke Pharma prices 11M shares at 68c in underwritten public offering
No recent news articles are available for EVOK
No recent press releases are available for EVOK
EVOK Financials
Key terms
Ad Feedback
EVOK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
EVOK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range